Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

Skin conditions, diet choices, and some chronic health conditions may make the bottom of your feet yellow. Treating the cause ...

New York-Presbyterian filed plans Thursday to construct a new oncology infusion suite at its Queens hospital, becoming the ...

The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

Ascentage Pharma Group International (($HK:6855)) announced an update on their ongoing clinical study. Study Overview: Ascentage Pharma Group Inc.

Disc Medicine, Inc. (($IRON)) announced an update on their ongoing clinical study. Disc Medicine, Inc. is conducting a study titled RALLY-MF: A ...

Her treatment plan, including transfusions and medication ... Doctors diagnosed Davis with warm autoimmune hemolytic anemia, ...

Sources familiar with the situation tell PEOPLE the former president is doing well and responding to treatment Nicholas Rice is a Senior Editor for PEOPLE Magazine. He began working with the brand as ...

Chicago, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The global anemia drugs market was valued at US$ 15.7 billion in 2024 and is expected to reach US$ 30.1 billion by 2033, growing at a CAGR of 7.8% between ...

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Anemia Treatment Market Report by Disease Type, Therapy Class, Route of Administration, Countries and Company Analysis, 2025-2033" report has been added ...